Patrick Lin - Chief Business - Strategy Off at Processa Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Business - Strategy Off
Issuer Symbol: PCSA on Nasdaq
All Insider Reports: All Insider Reports

Patrick Lin - trading volume in the past year for Processa Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys	+43,500	100%	$0.7975	+$34,691
Sells
Net	+43,500	100%		+$34,691

Holdings reported by Patrick Lin for Processa Pharmaceuticals, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Restricted Stock Units	68,000	$42,603	$1.71	01 Oct 2025	Direct	Common Stock
Common Stock	43,500	$9,135	$0.2100	24 Jul 2025	Lin Family Trust Feb 4, 2024
Common Stock	38,727	$8,132	$0.2100	24 Jul 2025	Direct
Stock Options (Right to Buy)	204,000			01 Oct 2025	Direct	Common Stock
Warrants	21,750			29 Jan 2025	Lin Family Trust Feb 4, 2024	Common Stock

Transactions reported by Patrick Lin for Processa Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.